This paper reveals about Magnetic nanoparticles (Fe3O4) that were synthesized by thermal co-precipitation of ferric and ferrous chlorides. The sizes and structure of the particles were characterized using transmission electron microscopy TEM. The size of the particles was in the range between 9.7 and 56.4 nm. Cholesterol oxidase CHO was...
The potential of titanium dioxide nanoparticles for advanced photochemical applications has prompted a number of studies to analyze the size, phase, and morphology dependent properties. The paper work further reveals about titanium dioxide nanoparticles in water, to examine the effects of various adsorption configurations on the equilibrium shape and the...
The paper reveals that certain amphiphilic polymers such as PEO-PPO-PEO triblock copolymer PL can directly disperse a cubic glycolipid, 1-O-phytanyl--D-xyloside (-XP), into bicontinuous cubic nanoparticles in water medium. The use of synchrotron small-angle X-ray diffraction SSAXD permitted the identification of the exact structure of these dispersed particles in the colloidal...
Findings Published in Nature Medicine CAMBRIDGE, Mass. -- T2 Biosystems, Inc., a company developing the first portable medical diagnostic products which combine nanotechnology and miniaturized magnetic resonance MR technology, today announced significant research findings that demonstrate the superior efficacy of the Company's nanoparticle-based, magnetic resonance diagnostic technology in...
EDEN PRAIRIE, Minn. -- SurModics, Inc. (Nasdaq:SRDX), a leading provider of surface modification and drug delivery technologies to the healthcare industry, announced today that its Brookwood Pharmaceuticals subsidiary has licensed lipid nanoparticle technology from PharmaSol GmbH of Berlin, Germany. Under the agreement, Brookwood has exclusive rights to all pharmaceutical applications...
California researchers say they have developed molecular "smart bombs" that stop pancreatic and kidney cancer from spreading in mice while causing fewer side effects and damage to healthy surrounding tissues than traditional chemotherapy. A team from the University of California, San Diego, designed a "nanoparticle" anti-cancer drug delivery system that...
SANTA CLARA, Calif. -- Agilent Technologies Inc. (NYSE:A) today announced it has acquired Particle Sizing Systems, a privately held company that designs and manufactures instruments that measure the particle size and stability in materials ranging from soft drinks to inkjet inks to semiconductor polishing slurries. Financial terms were not disclosed....
Event to focus on nanomedical applications in diagnostics, imaging, and therapeutics CLEVELAND, July 8 /PRNewswire/ -- The Nano-Network, Cleveland Clinic Lerner Research Institute, and Case Western Reserve University today announced the organizations will partner to host a national summit to explore the use of nanoparticles for diagnostics,...
Mr. LuVerne E.W. Hogg, President and CEO of ZEOX Corporation (The "Company" or "ZEOX") (TSX VENTURE: ZOX) is pleased to announce that the Company has purchased an additional 8% of ZEOX Performance Materials, LLC ("ZPM") from Cheto Partners, LLC, a company controlled by a director of the Company. The acquisition...
AlphaRx's inhaled Tobramycin nanoparticles demonstrated superior therapeutic efficacy in mouse models of acute Pseudomonas aeruginosa pneumonia. ZysolinTM could be a first-in-class anti-infective nanomedicine MARKHAM, ON, June 26 /PRNewswire-FirstCall/ -- AlphaRx (OTC BB:ALRX) is pleased to report additional pre-clinical data on ZysolinTM, an inhaled Tobramycin nanoparticles intended for...
Avanta AC[TM] Advanced Ceramics Solutions Offer Unique Advantages over Inorganic Bases in the Manufacture of Advanced Ceramic Nanoparticles AUSTIN, Texas -- SACHEM has published a white paper titled "Avanta AC[TM] Advanced Ceramics Solutions as Enablers for Advanced Ceramic Nanopowders" online. This white paper outlines the challenges in manufacturing...
BETHLEHEM, Pa., June 23 /PRNewswire/ -- A new blood test may make it easier for oncologists to accurately measure and personalize 5-fluorouracil (5-FU) dosing for patients undergoing continuous infusion chemotherapy regimens. Data from a multicenter trial showed that a nanoparticle-based immunoassay from Saladax Biomedical, called 5-FU Personalized Chemotherapy Management...
Geisinger's Neuroscience Institute Using In-Vivo Multispectral Imaging System to Advance Brain Cancer Research NEW HAVEN, Conn. -- Geisinger Health System's Neuroscience Institute is using the latest optical molecular imaging technology from Carestream Molecular Imaging as part of its cutting-edge research of brain cancer treatment. The objective of this...
SOUTHFIELD, Mich., June 23 /PRNewswire/ -- CerMet Lab Company has received a U.S. patent for a nano-particle ceramic conditioner product that restores metal and reduces friction in metal-to-metal environments. The process has proven to significantly improve fuel economy in both diesel and gas-powered engines, as well as provide energy...
PASADENA, Calif. -- Calando Pharmaceuticals, a majority-owned subsidiary of Arrowhead Research Corporation (NASDAQ:ARWR), announced today that it has entered into a collaboration with City of Hope in Duarte, CA to initiate an investigator sponsored clinical trial using Calando's nanoparticle drug candidate, IT-101, in patients with various forms of lymphoma. ...
NEW BRUNSWICK, N.J., June 5 /PRNewswire-FirstCall/ -- Senesco Technologies, Inc. ("Senesco" or the "Company") announced today further details of its continuing preclinical multiple myeloma research. In February 2008, the Company announced results of preclinical animal studies in which Senesco's Factor 5A technology, encapsulated in nanoparticles, was able...
Former Raytheon and C-COR Executive David Woodle Takes Helm as Chairman and CEO STATE COLLEGE, Pa. -- NanoHorizons Inc. today announced that it has raised approximately $6.7 million in a second round of funding from Penn Venture Partners, L.P., Life Sciences Greenhouse of Central Pennsylvania, and a number...
AlphaRx's specially-formulated Tobramycin nanoparticles increase survival rate in mice infected with Gram negative Pseudomonas Aeruginosa, suggesting Zysolin has potential in the treatment of Cystic Fibrosis and Gram-negative pneumonia. MARKHAM, ON, June 3 /PRNewswire-FirstCall/ -- AlphaRx (OTC BB:ALRX) is pleased to announce pre-clinical data on ZysolinTM, a Tobramycin...
SPRING HOUSE, Pa. -- Managers and researchers from Rohm and Haas Company (NYSE:ROH) presented the 4th annual Rohm and Haas New Faculty Award to Alfred J. Crosby, Ph.D. during his award lecture, "Wrinkling, Crumpling, and Snapping Polymer Surfaces," at the Rohm and Haas Spring House Technical Center last week. ...
Aduro to Focus on NT[TM] and TNT[TM] Systems for Solid Tumor Cancers BERKELEY, Calif. -- Two early stage cancer therapy companies, Oncologic and Triton BioSystems, have merged to create Aduro BioTech. Aduro, which is privately held, will be headquartered at the former Oncologic facility in Berkeley, California. ...
Articles 2008-06-02
<< Previous
page 1 of 1
Next >>
Premier Vendor Content
Whitepapers, webcasts & resources from our Power Center Sponsors
